Literature DB >> 22842231

Exome sequencing identifies NMNAT1 mutations as a cause of Leber congenital amaurosis.

Pei-Wen Chiang1, Juan Wang, Yang Chen, Quan Fu, Jing Zhong, Yanhua Chen, Xin Yi, Renhua Wu, Haixue Gan, Yong Shi, Yanling Chen, Christopher Barnett, Dianna Wheaton, Megan Day, Joanne Sutherland, Elise Heon, Richard G Weleber, Luis Alexandre Rassi Gabriel, Peikuan Cong, KuangHsiang Chuang, Sheng Ye, Juliana Maria Ferraz Sallum, Ming Qi.   

Abstract

Leber congenital amaurosis (LCA) is an autosomal recessive retinal dystrophy that manifests with genetic heterogeneity. We sequenced the exome of an individual with LCA and identified nonsense (c.507G>A, p.Trp169*) and missense (c.769G>A, p.Glu257Lys) mutations in NMNAT1, which encodes an enzyme in the nicotinamide adenine dinucleotide (NAD) biosynthesis pathway implicated in protection against axonal degeneration. We also found NMNAT1 mutations in ten other individuals with LCA, all of whom carry the p.Glu257Lys variant.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22842231     DOI: 10.1038/ng.2370

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  14 in total

1.  A Ufd2/D4Cole1e chimeric protein and overexpression of Rbp7 in the slow Wallerian degeneration (WldS) mouse.

Authors:  L Conforti; A Tarlton; T G Mack; W Mi; E A Buckmaster; D Wagner; V H Perry; M P Coleman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-10-10       Impact factor: 11.205

Review 2.  Wallerian degeneration, wld(s), and nmnat.

Authors:  Michael P Coleman; Marc R Freeman
Journal:  Annu Rev Neurosci       Date:  2010       Impact factor: 12.449

3.  Structure of human NMN adenylyltransferase. A key nuclear enzyme for NAD homeostasis.

Authors:  Silvia Garavaglia; Igor D'Angelo; Monica Emanuelli; Francesco Carnevali; Francesca Pierella; Giulio Magni; Menico Rizzi
Journal:  J Biol Chem       Date:  2001-12-19       Impact factor: 5.157

4.  Reducing expression of NAD+ synthesizing enzyme NMNAT1 does not affect the rate of Wallerian degeneration.

Authors:  Laura Conforti; Lucie Janeckova; Diana Wagner; Francesca Mazzola; Lucia Cialabrini; Michele Di Stefano; Giuseppe Orsomando; Giulio Magni; Caterina Bendotti; Neil Smyth; Michael Coleman
Journal:  FEBS J       Date:  2011-06-14       Impact factor: 5.542

Review 5.  Lighting a candle in the dark: advances in genetics and gene therapy of recessive retinal dystrophies.

Authors:  Anneke I den Hollander; Aaron Black; Jean Bennett; Frans P M Cremers
Journal:  J Clin Invest       Date:  2010-09-01       Impact factor: 14.808

6.  Structure of human nicotinamide/nicotinic acid mononucleotide adenylyltransferase. Basis for the dual substrate specificity and activation of the oncolytic agent tiazofurin.

Authors:  Tianjun Zhou; Oleg Kurnasov; Diana R Tomchick; Derk D Binns; Nick V Grishin; Victor E Marquez; Andrei L Osterman; Hong Zhang
Journal:  J Biol Chem       Date:  2002-01-11       Impact factor: 5.157

7.  Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene.

Authors:  T G Mack; M Reiner; B Beirowski; W Mi; M Emanuelli; D Wagner; D Thomson; T Gillingwater; F Court; L Conforti; F S Fernando; A Tarlton; C Andressen; K Addicks; G Magni; R R Ribchester; V H Perry; M P Coleman
Journal:  Nat Neurosci       Date:  2001-12       Impact factor: 24.884

8.  Identification of a locus (LCA9) for Leber's congenital amaurosis on chromosome 1p36.

Authors:  T Jeffrey Keen; Moin D Mohamed; Martin McKibbin; Yasmin Rashid; Hussain Jafri; Irene H Maumenee; Chris F Inglehearn
Journal:  Eur J Hum Genet       Date:  2003-05       Impact factor: 4.246

9.  Deducing the pathogenic contribution of recessive ABCA4 alleles in an outbred population.

Authors:  Emily I Schindler; Erik L Nylen; Audrey C Ko; Louisa M Affatigato; Andrew C Heggen; Kai Wang; Val C Sheffield; Edwin M Stone
Journal:  Hum Mol Genet       Date:  2010-07-20       Impact factor: 6.150

10.  Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial.

Authors:  Albert M Maguire; Katherine A High; Alberto Auricchio; J Fraser Wright; Eric A Pierce; Francesco Testa; Federico Mingozzi; Jeannette L Bennicelli; Gui-shuang Ying; Settimio Rossi; Ann Fulton; Kathleen A Marshall; Sandro Banfi; Daniel C Chung; Jessica I W Morgan; Bernd Hauck; Olga Zelenaia; Xiaosong Zhu; Leslie Raffini; Frauke Coppieters; Elfride De Baere; Kenneth S Shindler; Nicholas J Volpe; Enrico M Surace; Carmela Acerra; Arkady Lyubarsky; T Michael Redmond; Edwin Stone; Junwei Sun; Jennifer Wellman McDonnell; Bart P Leroy; Francesca Simonelli; Jean Bennett
Journal:  Lancet       Date:  2009-10-23       Impact factor: 79.321

View more
  60 in total

Review 1.  Location, Location, Location: Compartmentalization of NAD+ Synthesis and Functions in Mammalian Cells.

Authors:  Xiaolu A Cambronne; W Lee Kraus
Journal:  Trends Biochem Sci       Date:  2020-06-25       Impact factor: 13.807

2.  Severe biallelic loss-of-function mutations in nicotinamide mononucleotide adenylyltransferase 2 (NMNAT2) in two fetuses with fetal akinesia deformation sequence.

Authors:  Marshall Lukacs; Jonathan Gilley; Yi Zhu; Giuseppe Orsomando; Carlo Angeletti; Jiaqi Liu; Xiuna Yang; Joun Park; Robert J Hopkin; Michael P Coleman; R Grace Zhai; Rolf W Stottmann
Journal:  Exp Neurol       Date:  2019-05-25       Impact factor: 5.330

3.  NMNAT1 variants cause cone and cone-rod dystrophy.

Authors:  Benjamin M Nash; Richard Symes; Himanshu Goel; Marcel E Dinger; Bruce Bennetts; John R Grigg; Robyn V Jamieson
Journal:  Eur J Hum Genet       Date:  2017-11-28       Impact factor: 4.246

Review 4.  NMNAT: It's an NAD+ synthase… It's a chaperone… It's a neuroprotector.

Authors:  Jennifer M Brazill; Chong Li; Yi Zhu; R Grace Zhai
Journal:  Curr Opin Genet Dev       Date:  2017-04-23       Impact factor: 5.578

5.  Chaperoning the synapse--NMNAT protects Bruchpilot from crashing.

Authors:  Elsa Lauwers; Patrik Verstreken
Journal:  EMBO Rep       Date:  2012-11-30       Impact factor: 8.807

6.  Comprehensive analysis of genetic variations in strictly-defined Leber congenital amaurosis with whole-exome sequencing in Chinese.

Authors:  Shi-Yuan Wang; Qi Zhang; Xiang Zhang; Pei-Quan Zhao
Journal:  Int J Ophthalmol       Date:  2016-09-18       Impact factor: 1.779

Review 7.  Clinical and genetic findings in a family with NMNAT1-associated Leber congenital amaurosis: case report and review of the literature.

Authors:  A Hedergott; A E Volk; P Herkenrath; H Thiele; J Fricke; J Altmüller; P Nürnberg; C Kubisch; A Neugebauer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-10-13       Impact factor: 3.117

Review 8.  NAD+ and sirtuins in retinal degenerative diseases: A look at future therapies.

Authors:  Jonathan B Lin; Rajendra S Apte
Journal:  Prog Retin Eye Res       Date:  2018-06-12       Impact factor: 21.198

9.  Cobalamin C Deficiency Shows a Rapidly Progressing Maculopathy With Severe Photoreceptor and Ganglion Cell Loss.

Authors:  Lucas Bonafede; Can H Ficicioglu; Leona Serrano; Grace Han; Jessica I W Morgan; Monte D Mills; Brian J Forbes; Stefanie L Davidson; Gil Binenbaum; Paige B Kaplan; Charles W Nichols; Patrick Verloo; Bart P Leroy; Albert M Maguire; Tomas S Aleman
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-12       Impact factor: 4.799

Review 10.  NMNATs, evolutionarily conserved neuronal maintenance factors.

Authors:  Yousuf O Ali; David Li-Kroeger; Hugo J Bellen; R Grace Zhai; Hui-Chen Lu
Journal:  Trends Neurosci       Date:  2013-08-20       Impact factor: 13.837

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.